Home Cart Sign in  
Chemical Structure| 503468-95-9 Chemical Structure| 503468-95-9

Structure of KU-57788
CAS No.: 503468-95-9

Chemical Structure| 503468-95-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

NU7441 is a potent and selective DNA-PK inhibitor with IC50 of 14 nM and also inhibits PI3K with IC50 of 5 μM in cell-free assays.

Synonyms: NU7441

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of KU-57788

CAS No. :503468-95-9
Formula : C25H19NO3S
M.W : 413.49
SMILES Code : O=C1C=C(N2CCOCC2)OC3=C(C4=C5C(C6=CC=CC=C6S5)=CC=C4)C=CC=C13
Synonyms :
NU7441
MDL No. :MFCD11983069
InChI Key :JAMULYFATHSZJM-UHFFFAOYSA-N
Pubchem ID :11327430

Safety of KU-57788

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of KU-57788

epigenetics
DNA
PI3K-AKT

Isoform Comparison

Biological Activity

Target
  • PI3K

    PI3K, IC50:5 μM

  • DNA-PK

    DNA-PK, IC50:14 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
SLK cells 15 μM 2 h To evaluate the effect of KU-57788 on KSHV circularization in SLK cells. Results showed that KU-57788 significantly reduced KSHV circularization efficiency. PMC10899755
HDMVEC cells 15 μM 2 h To evaluate the effect of KU-57788 on KSHV circularization in HDMVEC cells. Results showed that KU-57788 significantly reduced KSHV circularization efficiency. PMC10899755
GBM cells 1 μM KU-57788 inhibited the activation of DNA-PKcs, reducing TMZ-induced DNA damage repair, thereby enhancing the cytotoxicity of TMZ on GBM cells. PMC8486800
SAS cells 5 μM 1 h Inhibited NHEJ repair of radiation-induced DSBs, TGF β inhibition partially rescued the repair PMC8208885
U2OS cells 2 μM 2 h To inhibit DNA-PK activity and study its effect on the induction of pUbT12 foci PMC7655664

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Ovarian cancer peritoneal metastasis model Oral 60 mg/kg Once daily for 21 days To evaluate the in vivo efficacy of HIPET combined with WEE1 inhibitor PMC10920785

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.42mL

0.48mL

0.24mL

12.09mL

2.42mL

1.21mL

24.18mL

4.84mL

2.42mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories